Home » Topics » Regulatory » Patents

Patents
RSS

Arisan Therapeutics presents RNA polymerase inhibitors

Oct. 19, 2016

Celon Pharma develops PI3Kdelta inhibitors

Oct. 19, 2016

Enanta Pharmaceuticals describes FXR agonists

Oct. 19, 2016

Shenyang Sunshine Pharmaceutical discloses EGLN1 inhibitors

Oct. 19, 2016

Takeda Pharmaceutical patents enteropeptidase inhibitors

Oct. 19, 2016

Toray Industries presents kappa-opioid agonists

Oct. 18, 2016

Jubilant Biosys develops HUNK1 inhibitors

Oct. 18, 2016

Takeda Pharmaceutical describes MGL inhibitors

Oct. 18, 2016

Sichuan Haisco Pharmaceutical patents M3 receptor antagonists and/or beta2-adrenoceptor agonists

Oct. 18, 2016

Mutabilis discloses beta-lactamase inhibitors

Oct. 18, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...